Page last updated: 2024-12-06

desmedipham

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

desmedipham: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

desmedipham : A carbamate ester that is phenylcarbamic acid in which the hydrogen of the hydroxy group has been replaced by a 3-[(ethoxycarbonyl)amino]phenyl group. It is an agrochemical used as a herbicide. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID24743
CHEMBL ID16024
CHEBI ID81733
SCHEMBL ID55084
MeSH IDM0042417

Synonyms (76)

Synonym
schering 38107
betanal am
ethyl 3'-phenylcarbamoyloxycarbanilate
3-(aethoxycarbonylaminophenyl)-n-phenyl-carbamat [german]
carbamic acid, phenylcarbamoyloxyphenyl-, ethyl ester
caswell no. 447aaa
ethyl 3-phenylcarbamoyloxyphenylcarbamate
brn 2395716
carbanilic acid, m-carbaniloyloxy-, ethyl ester
sn 38170
3-((ethoxycarbonyl)amino)phenyl phenylcarbamate
3-ethoxycarbonylaminophenyl-n-phenylcarbamate
betanal am 11
carbamic acid, (3-(((phenylamino)carbonyl)oxy)phenyl)-, ethyl ester
ethyl (3-(((phenylamino)carbonyl)oxy)phenyl)carbamate
ethyl m-hydroxycarbanilate carbanilate (ester)
einecs 237-198-5
epa pesticide chemical code 104801
desmediphame [iso-french]
ep-475
carbanilic acid, m-hydroxy-, ethyl ester, carbanilate (ester)
ethyl meta-hydroxycarbanilate carbanilate
bentanex
betanex
ethyl phenylcarbamoyloxyphenylcarbamate
sn 38107
desmedipham [ansi:bsi:iso]
synbetan d
carbamic acid, [3-[[(phenylamino)carbonyl]oxy]phenyl]-, ethyl ester
desmedipham
CBDIVE_001126
NCGC00163997-01
chebi:81733 ,
CHEMBL16024
[3-(ethoxycarbonylamino)phenyl] n-phenylcarbamate
13684-56-5
ethyl (3-((phenylcarbamoyl)oxy)phenyl)carbamate
A807148
C18417
desmediphame
c7v2ttx346 ,
unii-c7v2ttx346
ccris 9306
3-(aethoxycarbonylaminophenyl)-n-phenyl-carbamat
cas-13684-56-5
dtxcid8014518
tox21_301854
NCGC00255340-01
dtxsid0034518 ,
FT-0603107
AKOS015895883
3-ethoxycarbonylaminophenyl n-phenylcarbamate
n-(3-(((phenylamino)carbonyl)oxy)phenyl)carbamic acid ethyl ester
ethyl n-(3-(((phenylamino)carbonyl)oxy)phenyl)carbamate
carbamic acid, n-(3-(((phenylamino)carbonyl)oxy)phenyl)-, ethyl ester
sn-38107
ethyl 3-phenylcarbamoyloxycarbanilate
ethyl n-(3-(n-phenylcarbamoyloxy)phenyl)carbamate
ethyl m-hydroxycarbanilate carbanilate
desmedipham [iso]
desmedipham [mi]
SCHEMBL55084
3-[(ethoxycarbonyl)amino]phenyl phenylcarbamate
WZJZMXBKUWKXTQ-UHFFFAOYSA-N
ethyl n-[3-(n-phenylcarbamoyloxy)phenyl]carbamate
desmedipham, pestanal(r), analytical standard
J-006923
tiancaian
Q3024527
HY-116482
CS-0065617
ep475
carbamic acid, n-[3-[[(phenylamino)carbonyl]oxy]phenyl]-, ethyl ester
ethyl-3-phenylcarbamoyloxyphenylcarbamate
BS-42120
ethyl-m-hydroxycarbanilate(ester)

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The dry matter dose-response relationships and the energy pipeline presentation confirmed the same trend."( Monitoring the efficacy and metabolism of phenylcarbamates in sugar beet and black nightshade by chlorophyll fluorescence parameters.
Abbaspoor, M; Streibig, JC, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
xenobioticA xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
herbicideA substance used to destroy plant pests.
agrochemicalAn agrochemical is a substance that is used in agriculture or horticulture.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (18)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency31.70550.007215.758889.3584AID1224835
pregnane X receptorRattus norvegicus (Norway rat)Potency50.11870.025127.9203501.1870AID651751
RAR-related orphan receptor gammaMus musculus (house mouse)Potency5.22040.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency17.59540.000221.22318,912.5098AID1259243; AID1259247; AID588515; AID743042; AID743054
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency19.33120.013326.981070.7614AID1346978
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency27.38300.001022.650876.6163AID1224838; AID1224839; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency14.85860.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency19.47140.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency50.71630.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency11.34720.000229.305416,493.5996AID1259244; AID1259248; AID1259383; AID743075; AID743079; AID743080; AID743091
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency54.94100.023723.228263.5986AID743222
caspase-3Homo sapiens (human)Potency19.33120.013326.981070.7614AID1346978
aryl hydrocarbon receptorHomo sapiens (human)Potency45.90730.000723.06741,258.9301AID651777; AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency5.44830.001723.839378.1014AID743083
histone deacetylase 9 isoform 3Homo sapiens (human)Potency5.35800.037617.082361.1927AID1259364; AID1259388
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency29.35640.000627.21521,122.0200AID651741; AID720636
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency5.44830.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency5.44830.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.17 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index45.55 (26.88)
Search Engine Supply Index2.06 (0.95)

This Compound (36.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]